- Condition: Laparoscopic Hysterectomy
Intervention: Drug: Fleet Enema (sodium biphosphate and sodium phosphate)
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill
Recruiting - verified April 2012 - Condition: Impaired Fasting Glucose
Interventions: Dietary Supplement: psyllium; Dietary Supplement: Microcrystalline Cellulose
Sponsors: Procter and Gamble; Procter and Gamble; Duke University
Recruiting - verified March 2012 - Condition: Diabetes Mellitus
Interventions: Drug: Golytely (polyethylene glycol electrolyte lavage solution) and placebo; Drug: split dose of Golytely (polyethylene glycol electrolyte lavage solution) + placebo; Drug: split dose of Golytely (polyethylene glycol electrolyte lavage solution) and bisacodyl
Sponsors: University of Oklahoma; University of Oklahoma
Recruiting - verified February 2012 - Conditions: Gestational Diabetes; Obesity
Interventions: Dietary Supplement: Magnesium citrate; Dietary Supplement: Placebo; Behavioral: Dietary modification
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified January 2012 - Conditions: Acute Lymphoblastic Leukemia; Precursor B-Cell Lymphoblastic Leukemia; Precursor T-Cell Lymphoblastic Leukemia
Interventions: Drug: Decitabine; Drug: Vorinostat; Drug: Vincristine; Drug: Dexamethasone; Drug: Mitoxantrone; Drug: Pegaspargase; Drug: Methotrexate
Sponsors: Therapeutic Advances in Childhood Leukemia Consortium; Therapeutic Advances in Childhood Leukemia Consortium
Recruiting - verified March 2012 - Condition: Primary Biliary Cirrhosis
Interventions: Drug: Obeticholic Acid (OCA); Drug: Placebo
Sponsors: Intercept Pharmaceuticals; Intercept Pharmaceuticals
Recruiting - verified May 2012 - Condition: Colon Cleansing
Interventions: Drug: Polyethylene glycol; Drug: Oral sodium phosphate solution
Sponsors: Salix Pharmaceuticals; Salix Pharmaceuticals
Recruiting - verified January 2012 - Condition: Constipation
Interventions: Other: Opioid Dose Intervention; Other: Opioid Assessment Intervention; Other: Vinca Alkaloid Assessment Intervention
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; National Institutes of Health (NIH); University of South Florida
Recruiting - verified January 2012 - Condition: Value of the Bowel Preparation Versus Diet Change
Interventions: Other: No bowel prep; Other: Clear liquid diet and 2 Fleet's enemas
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Recruiting - verified April 2012 - Conditions: Venous Ulcer; Infection
Interventions: Device: Restore Calcium Alginate Dressing; Device: AquaCel Ag Wound Dressing
Sponsors: Hollister Wound Care LLC; Hollister Wound Care LLC
Recruiting - verified November 2011 - Condition: Dry Eye Syndromes
Interventions: Drug: Altaire Gel forming solution; Drug: Refresh Tears
Sponsors: Innovative Medical; Innovative Medical
Recruiting - verified June 2011 - Condition: Healthy Volunteers
Intervention: Drug: Poly ICLC
Sponsors: Rockefeller University; Rockefeller University
Recruiting - verified January 2012 - Condition: Hyponatremia
Interventions: Drug: PEG-SD; Drug: PEG-ELS
Sponsors: Thomas Jefferson University; Thomas Jefferson University; Salix Pharmaceuticals
Recruiting - verified November 2011 - Condition: Preterm Delivery
Interventions: Drug: 17-alpha-hydroxy-progesterone caproate, Makena®; Drug: Castor Oil (Placebo)
Sponsors: Obstetrix Medical Group; Obstetrix Medical Group
Recruiting - verified March 2012 - Condition: Corneal Neovascularization
Interventions: Drug: Avastin (bevacizumab); Drug: 0.9% NaCl & Refresh Liquigel
Sponsors: Massachusetts Eye and Ear Infirmary; Massachusetts Eye and Ear Infirmary
Recruiting - verified April 2012 - Condition: Pregnancy Complications
Intervention: Drug: 17-Hydroxyprogesterone Caproate vs Castor oil (placebo)
Sponsors: Stanford University; Stanford University
Recruiting - verified April 2012 - Conditions: Postoperative Nausea and Vomiting; Abdominal Pain
Interventions: Drug: Bisacodyl; Drug: placebo
Sponsors: The Cooper Health System; The Cooper Health System
Recruiting - verified September 2011 - Conditions: Breast Cancer; Inflammatory Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Triple-negative Breast Cancer
Interventions: Biological: MUC-1 peptide vaccine; Biological: poly ICLC; Biological: MUC1 peptide-poly-ICLC adjuvant vaccine; Other: laboratory biomarker analysis; Other: enzyme-linked immunosorbent assay; Other: flow cytometry
Sponsors: Case Comprehensive Cancer Center; Case Comprehensive Cancer Center
Recruiting - verified March 2012 - Condition: Fecal Incontinence
Interventions: Drug: Psyllium powder; Drug: Loperamide
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified February 2012
 |
Cathartics Clinical Trials |
